Royalty Pharma Announces Upcoming Investor Day
Royalty Pharma (Nasdaq: RPRX) has announced plans to host an Investor Day on September 11, 2025, in New York City. The event will commence at 8:30 a.m. ET.
During the event, senior executives will present updates on the company's strategy for creating shareholder value by leveraging its distinctive business model and capabilities in the biopharma innovation funding market. The presentation will include interactive Q&A sessions.
Investors can access the live webcast through the 'Investors' section of Royalty Pharma's website, where it will remain archived for at least thirty days.
Royalty Pharma (Nasdaq: RPRX) ha annunciato piani per ospitare un Investor Day l'11 settembre 2025, a New York City. L'evento avrà inizio alle 8:30 a.m. ET.
Durante l'evento, i dirigenti senior presenteranno aggiornamenti sulla strategia dell'azienda per creare valore per gli azionisti sfruttando il suo modello di business distintivo e le capacità nel mercato del finanziamento dell'innovazione biopharma. La presentazione includerà sessioni interattive di domande e risposte.
Gli investitori possono accedere alla diretta streaming tramite la sezione 'Investitori' del sito web di Royalty Pharma, dove rimarrà archiviata per almeno trenta giorni.
Royalty Pharma (Nasdaq: RPRX) ha anunciado planes para llevar a cabo un Día del Inversor el 11 de septiembre de 2025, en la ciudad de Nueva York. El evento comenzará a las 8:30 a.m. ET.
Durante el evento, ejecutivos senior presentarán actualizaciones sobre la estrategia de la empresa para crear valor para los accionistas aprovechando su modelo de negocio distintivo y capacidades en el mercado de financiamiento de innovación biopharma. La presentación incluirá sesiones interactivas de preguntas y respuestas.
Los inversores pueden acceder a la transmisión en vivo a través de la sección 'Inversores' del sitio web de Royalty Pharma, donde permanecerá archivada por al menos treinta días.
로열티 제약 (Nasdaq: RPRX)는 2025년 9월 11일 뉴욕시에서 투자자 데이를 개최할 계획을 발표했습니다. 이벤트는 오전 8시 30분(ET)부터 시작됩니다.
이벤트 동안 고위 경영진이 회사의 독특한 비즈니스 모델과 바이오제약 혁신 자금 조달 시장에서의 역량을 활용하여 주주 가치를 창출하기 위한 전략에 대한 업데이트를 발표합니다. 발표에는 인터랙티브한 Q&A 세션도 포함됩니다.
투자자는 로열티 제약 웹사이트의 '투자자' 섹션을 통해 실시간 웹캐스트에 접근할 수 있으며, 최소 30일 동안 아카이브로 남아있습니다.
Royalty Pharma (Nasdaq: RPRX) a annoncé des plans pour organiser un Investor Day le 11 septembre 2025 à New York. L'événement commencera à 8h30 ET.
Lors de cet événement, des cadres supérieurs présenteront des mises à jour sur la stratégie de l'entreprise visant à créer de la valeur pour les actionnaires en tirant parti de son modèle commercial distinctif et de ses capacités sur le marché du financement de l'innovation biopharmaceutique. La présentation comprendra des sessions de questions-réponses interactives.
Les investisseurs peuvent accéder à la diffusion en direct via la section 'Investisseurs' du site Web de Royalty Pharma, où elle restera archivée pendant au moins trente jours.
Royalty Pharma (Nasdaq: RPRX) hat Pläne angekündigt, am 11. September 2025 einen Investor Day in New York City auszurichten. Die Veranstaltung beginnt um 8:30 Uhr ET.
Während der Veranstaltung werden leitende Führungskräfte Updates zur Unternehmensstrategie präsentieren, um den Aktionärswert durch die Nutzung ihres einzigartigen Geschäftsmodells und ihrer Fähigkeiten im Bereich der Finanzierung von biopharmazeutischen Innovationen zu steigern. Die Präsentation wird interaktive Q&A-Sitzungen beinhalten.
Investoren können über den Bereich 'Investoren' auf der Website von Royalty Pharma auf den Live-Webcast zugreifen, der mindestens dreißig Tage lang archiviert bleibt.
- None.
- None.
NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will host an Investor Day in New York City on Thursday, September 11, 2025, starting at 8:30 a.m. ET. Royalty Pharma senior executives will provide an update on the company’s plans to drive shareholder value creation through leveraging its unique business model and capabilities in the large and growing market for funding biopharma innovation. The meeting will include live question and answer sessions.
Additional details will follow closer to the event. The live webcast may be accessed from the “Investors” page of the company’s website at https://www.royaltypharma.com/investors/events/. The webcast will also be archived for a minimum of thirty days.
About Royalty Pharma
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 15 development-stage product candidates. For more information, visit www.royaltypharma.com.
Royalty Pharma Investor Relations and Communications
+1 (212) 883-6637
ir@royaltypharma.com
FAQ
When and where is Royalty Pharma (RPRX) hosting its 2025 Investor Day?
How can investors access RPRX's 2025 Investor Day presentation?
What topics will be covered at Royalty Pharma's 2025 Investor Day?
Will there be a Q&A session during RPRX's 2025 Investor Day?
